EGF receptor inhibitors comprehensively suppress hepatitis B virus by downregulation of STAT3 phosphorylation

Current antiviral therapy can not cure chronic hepatitis B virus (HBV) infection or eliminate the risk of hepatocellular carcinoma. The licensed epidermal growth factor receptor (EGFR) inhibitors have found to inhibit hepatitis C virus replication via downregulation of signal transducers and activat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gan, Chong J., Li, Wen F., Li, Chun N., Li, Ling L., Zhou, Wen Y., Peng, Xiao M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170955/
https://www.ncbi.nlm.nih.gov/pubmed/32322693
http://dx.doi.org/10.1016/j.bbrep.2020.100763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170955/
https://www.ncbi.nlm.nih.gov/pubmed/32322693
http://dx.doi.org/10.1016/j.bbrep.2020.100763

Ejemplares similares